QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
NYSE:QGEN

Qiagen - QGEN Stock Forecast, Price & News

$49.66
-0.26 (-0.52%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$49.36
$49.96
50-Day Range
$46.01
$50.42
52-Week Range
$41.32
$58.00
Volume
792,528 shs
Average Volume
841,979 shs
Market Capitalization
$11.28 billion
P/E Ratio
19.40
Dividend Yield
N/A
Price Target
$54.50

Qiagen MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
9.7% Upside
$54.50 Price Target
Short Interest
Bearish
2.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.83
Upright™ Environmental Score
News Sentiment
0.44mentions of Qiagen in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-21.43%
From $2.52 to $1.98 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.59 out of 5 stars

Medical Sector

1052nd out of 1,125 stocks

Biological Products, Except Diagnostic Industry

171st out of 179 stocks

QGEN stock logo

About Qiagen (NYSE:QGEN) Stock

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Qiagen Trading Up 0.3 %

QGEN opened at $49.92 on Monday. The firm has a market cap of $11.34 billion, a price-to-earnings ratio of 19.50, a price-to-earnings-growth ratio of 2.15 and a beta of 0.23. Qiagen has a 52 week low of $41.32 and a 52 week high of $58.00. The business's 50 day moving average is $47.16 and its two-hundred day moving average is $47.27. The company has a quick ratio of 1.58, a current ratio of 1.90 and a debt-to-equity ratio of 0.52.

Receive QGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter.

QGEN Stock News Headlines

Estimating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Qiagen (NASDAQ:QGEN) Lowered to "Buy" at StockNews.com
Qiagen (NYSE:QGEN) Updates FY 2022 Earnings Guidance
Qiagen: Q2 Earnings Snapshot - Greenwich Time
Qiagen Raises FY Outlook
Qiagen: Q2 Earnings Snapshot
See More Headlines
Receive QGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter.

QGEN Company Calendar

Last Earnings
11/03/2021
Today
8/15/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Employees
6,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$54.50
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$49.00
Forecasted Upside/Downside
+9.7%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$359.19 million
Pretax Margin
32.00%

Debt

Sales & Book Value

Annual Sales
$1.87 billion
Cash Flow
$3.36 per share
Book Value
$12.27 per share

Miscellaneous

Free Float
207,466,000
Market Cap
$11.28 billion
Optionable
Optionable
Beta
0.23

Key Executives

  • Mr. Thierry Bernard (Age 57)
    CEO, MD & Member of Management Board
    Comp: $2.02M
  • Dr. Roland Sackers (Age 53)
    CFO, MD & Member of Management Board
    Comp: $1.18M
  • Mr. Antonio Santos
    Sr. VP & Head of Global Operations
  • Mr. John Gilardi
    VP of Corp. Communications & Investor Relations
  • Ms. Stephany Foster
    Sr. VP & Head of HR
  • Dr. Thomas Schweins
    Sr. VP of Life Science Bus. Area
  • Dr. Thomas Theuringer
    Sr. Director & Head of External Communications
  • Mr. Jean-Pascal Viola
    Sr. VP & Head of Molecular Diagnostics Bus. Area
  • Dr. Jonathan G. Sheldon Ph.D. (Age 50)
    Sr. VP of Qiagen Digital Insights Bus. Area
  • Mr. Thomas Neidert
    VP of Global Treasury













QGEN Stock - Frequently Asked Questions

Should I buy or sell Qiagen stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Qiagen in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" QGEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares.
View QGEN analyst ratings
or view top-rated stocks.

What is Qiagen's stock price forecast for 2022?

5 brokerages have issued 1-year target prices for Qiagen's stock. Their QGEN share price forecasts range from $49.00 to $60.00. On average, they anticipate the company's stock price to reach $54.50 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price.
View analysts price targets for QGEN
or view top-rated stocks among Wall Street analysts.

How have QGEN shares performed in 2022?

Qiagen's stock was trading at $55.58 at the start of the year. Since then, QGEN shares have decreased by 10.7% and is now trading at $49.66.
View the best growth stocks for 2022 here
.

When is Qiagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our QGEN earnings forecast
.

How were Qiagen's earnings last quarter?

Qiagen (NYSE:QGEN) posted its earnings results on Wednesday, November, 3rd. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.05. The business had revenue of $534.75 million for the quarter, compared to analysts' expectations of $487.35 million. Qiagen had a trailing twelve-month return on equity of 20.71% and a net margin of 26.61%. During the same quarter in the previous year, the business posted $0.58 EPS.

What guidance has Qiagen issued on next quarter's earnings?

Qiagen issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $2.30- for the period. The company issued revenue guidance of $2.20B-, compared to the consensus revenue estimate of $2.04 billion.

What is Thierry Bernard's approval rating as Qiagen's CEO?

33 employees have rated Qiagen Chief Executive Officer Thierry Bernard on Glassdoor.com. Thierry Bernard has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Qiagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Qiagen investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX).

What is Qiagen's stock symbol?

Qiagen trades on the New York Stock Exchange (NYSE) under the ticker symbol "QGEN."

Who are Qiagen's major shareholders?

Qiagen's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (9.00%), Pendal Group Ltd (1.41%), DekaBank Deutsche Girozentrale (0.94%), Millennium Management LLC (0.88%), Northern Trust Corp (0.52%) and Swiss National Bank (0.44%).

How do I buy shares of Qiagen?

Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Qiagen's stock price today?

One share of QGEN stock can currently be purchased for approximately $49.66.

How much money does Qiagen make?

Qiagen (NYSE:QGEN) has a market capitalization of $11.28 billion and generates $1.87 billion in revenue each year. The company earns $359.19 million in net income (profit) each year or $2.56 on an earnings per share basis.

How many employees does Qiagen have?

The company employs 6,000 workers across the globe.

How can I contact Qiagen?

Qiagen's mailing address is HULSTERWEG 82, VENLO P7, 5912. The official website for the company is www.qiagen.com. The company can be reached via phone at (177) 355-6600, via email at ir@qiagen.com, or via fax at 31-77-355-6658.

This page (NYSE:QGEN) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.